| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,892.80
|
|
Change (%)
|
-3.20 (-0.17%)
|
|
Best Buy (RS)
|
1890(x20)
|
|
Best Sell (RS)
|
1895(x71)
|
|
Today's Range (RS)
|
1,873.65
-
1,896.00
|
|
52-Week Range (RS)
|
1,583.60
-
2,047.55
|
|
Beta (1 Year)
|
0.43
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharmaceutical Industries Ltd up for third consecutive session |
| Sun Pharmaceutical Q2 PAT declines 36% YoY |
| Sun Pharma receives USFDA approval for ILUMYA® (tildrakizumab-asmn) |
| Sun Pharmaceutical Industries consolidated net profit declines 36.22% in the September 2026 quarter |
| Sun Pharma raises Rs 7,816 cr via NCDs |
| Sun Pharma announces elevation of UNLOXCYT to NCCN®) Category 2A recommendation |
| Volumes soar at L&T Technology Services Ltd counter |
| Sun Pharmaceuticals Industries announces board meeting date |
| Sun Pharma receives ratings action from ICRA |
| Sun Pharma receives affirmation in credit ratings from CRISIL |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
04-Nov-2026 |
1776.00 |
6.76 |
| 1Month |
12-Oct-2026 |
1759.10 |
7.78 |
| 3Month |
11-Aug-2026 |
1940.00 |
-2.27 |
| 6Month |
11-May-2026 |
1872.40 |
1.26 |
| 1Year |
11-Nov-2025 |
1716.05 |
10.49 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.76 |
3656.64 |
| SBI BSE SENSEX ETF |
2.17 |
2596.69 |
| ICICI Pru Value Fund |
4.24 |
2447.87 |
| ICICI Pru Aggressive Hybrid Fund |
3.50 |
1751.57 |
| HDFC Balanced Advantage Fund |
1.53 |
1554.84 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Laurus Labs Ltd |
2,395.00 |
-1.64 |
2,481.50 |
913.35 |
131,566.03 |
| Zydus Lifesciences Ltd |
1,205.00 |
1.25 |
1,266.15 |
835.85 |
118,712.93 |
| Dr Reddys Laboratories Ltd |
1,384.00 |
0.58 |
1,414.40 |
1,080.05 |
114,933.37 |
| Cipla Ltd |
1,403.00 |
-0.99 |
1,539.25 |
1,165.55 |
114,477.74 |
| Mankind Pharma Ltd |
2,632.00 |
-0.94 |
2,705.00 |
1,909.90 |
109,746.08 |
|
|
|
|